Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Details) - Schedule of statement of operations

v3.22.1
Restatement of Previously Issued Financial Statements (Details) - Schedule of statement of operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Previously Reported [Member]    
Condensed Income Statements, Captions [Line Items]    
Operating and formation costs $ 417,261 $ 417,261
Warrant issuance costs (256,379) (256,379)
Change in fair value of warrant liabilities 4,037,000 4,037,000
Change in fair value of over-allotment option liability
Net income (loss) $ 3,341,073 $ 3,341,073
Diluted net income (loss) per share of common stock (in Dollars per share) $ 0.19 $ 0.34
Revision of Prior Period, Adjustment [Member]    
Condensed Income Statements, Captions [Line Items]    
Operating and formation costs $ (431) $ (431)
Warrant issuance costs 101,342 101,342
Change in fair value of warrant liabilities (7,656,500) (7,656,500)
Change in fair value of over-allotment option liability (225,000) (225,000)
Net income (loss) $ (7,779,727) $ (7,779,727)
Diluted net income (loss) per share of common stock (in Dollars per share) $ (0.44) $ (0.87)
As Restated [Member]    
Condensed Income Statements, Captions [Line Items]    
Operating and formation costs $ 416,830 $ 416,830
Warrant issuance costs (155,037) (155,037)
Change in fair value of warrant liabilities (3,619,500) (3,619,500)
Change in fair value of over-allotment option liability (225,000) (225,000)
Net income (loss) $ (4,438,654) $ (4,438,654)
Diluted net income (loss) per share of common stock (in Dollars per share) $ (0.25) $ (0.53)